Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at scale while managing large territories and diverse customer bases.
Kunal Girotra
Advertisement
Senior Manager, Strategy & Enablement, Pfizer
Articles by Kunal Girotra
Advertisement
Latest Updated Articles
Beyond the Data: Making HCP Analytics Actually Work for Commercial TeamsPublished: February 21st 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma
2
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX
3
FDA Continues to Expand National Priority Voucher Program
4
Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?
5
